David Tuller
Trial By Error: “Talk is Cheap,” Patients Tell NIH
By David Tuller
By David Tuller, DrPH Earlier this month, NIH director Francis Collins and other agency officials held a meeting with five representatives from #MEAction. According to the group’s post about the meeting, the goal was to discuss accelerating research in order to more rapidly provide diagnostics and treatments to people with ...
Trial By Error: Australian Draft Report Seeks Comments
By David Tuller
By David Tuller, DrPH In an eagerly awaited draft report, an Australian advisory committee on ME/CFS has called for the development of up-to-date domestic clinical guidelines and an increase in biomedical research into the pathophysiology of the illness. The draft report, which could have a major impact on health policy ...
Trial By Error: The New Interferon “CFS” Study
By David Tuller
By David Tuller, DrPH I haven't had time to cover the new and wildly over-hyped study about prolonged fatigue--and purportedly about "chronic fatigue syndrome"--that was published this week in the journal Psychoneuroendocrinology. Thanks no doubt to the involvement of the Science Media Centre, this mildly interesting piece of research has ...
Trial By Error: The View From Norway
By David Tuller
By David Tuller, DrPH I spent the last week of November in Oslo. The Norwegian ME Association invited me to give a couple of talks and have some meetings with public health officials. The city was charming, even if dark and overcast at this time of year. Not surprisingly, the ...
Trial By Error: And Cochrane Makes Another Move…
By David Tuller
By David Tuller, DrPH Yet another interesting development has taken place at Cochrane, and this new development again suggests that things there might be moving in the right direction. On Friday, the organization withdrew a protocol for what is called an individual patient data (or IPD) review of exercise therapy ...
